| Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2 J Huo, A Le Bas, RR Ruza, HME Duyvesteyn, H Mikolajek, T Malinauskas, ... Nature structural & molecular biology 27 (9), 846-854, 2020 | 479 | 2020 |
| Neutralization of SARS-CoV-2 by destruction of the prefusion spike J Huo, Y Zhao, J Ren, D Zhou, HME Duyvesteyn, HM Ginn, L Carrique, ... Cell host & microbe 28 (3), 445-454. e6, 2020 | 368 | 2020 |
| Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient D Zhou, HME Duyvesteyn, CP Chen, CG Huang, TH Chen, SR Shih, ... Nature structural & molecular biology 27 (10), 950-958, 2020 | 287 | 2020 |
| A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses TK Tan, P Rijal, R Rahikainen, AH Keeble, L Schimanski, S Hussain, ... Nature communications 12 (1), 542, 2021 | 234 | 2021 |
| Systematic analysis of monoclonal antibodies against Ebola virus GP defines features that contribute to protection EO Saphire, SL Schendel, ML Fusco, K Gangavarapu, BM Gunn, AZ Wec, ... Cell 174 (4), 938-952. e13, 2018 | 191 | 2018 |
| Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern DT Skelly, AC Harding, J Gilbert-Jaramillo, ML Knight, S Longet, A Brown, ... Nature communications 12 (1), 5061, 2021 | 155 | 2021 |
| Focused antibody response to influenza linked to antigenic drift KYA Huang, P Rijal, L Schimanski, TJ Powell, TY Lin, JW McCauley, ... The Journal of clinical investigation 125 (7), 2631-2645, 2015 | 138 | 2015 |
| Therapeutic monoclonal antibodies for Ebola virus infection derived from vaccinated humans P Rijal, SC Elias, SR Machado, J Xiao, L Schimanski, V O’Dowd, T Baker, ... Cell reports 27 (1), 172-186. e7, 2019 | 72 | 2019 |
| Breadth and function of antibody response to acute SARS-CoV-2 infection in humans KYA Huang, TK Tan, TH Chen, CG Huang, R Harvey, S Hussain, ... Plos pathogens 17 (2), e1009352, 2021 | 71 | 2021 |
| A haemagglutination test for rapid detection of antibodies to SARS-CoV-2 A Townsend, P Rijal, J Xiao, TK Tan, KYA Huang, L Schimanski, J Huo, ... Nature communications 12 (1), 1951, 2021 | 62 | 2021 |
| Overcoming symmetry mismatch in vaccine nanoassembly through spontaneous amidation R Rahikainen, P Rijal, TK Tan, HJ Wu, AMC Andersson, JR Barrett, ... Angewandte Chemie International Edition 60 (1), 321-330, 2021 | 61 | 2021 |
| Secondary influenza challenge triggers resident memory B cell migration and rapid relocation to boost antibody secretion at infected sites AJ MacLean, N Richmond, L Koneva, M Attar, CAP Medina, EE Thornton, ... Immunity 55 (4), 718-733. e8, 2022 | 59 | 2022 |
| Altered peptide ligands revisited: Vaccine design through chemically modified HLA-A2–restricted T cell epitopes R Hoppes, R Oostvogels, JJ Luimstra, K Wals, M Toebes, L Bies, ... The Journal of Immunology 193 (10), 4803-4813, 2014 | 59 | 2014 |
| Vaccine-induced immunity provides more robust heterotypic immunity than natural infection to emerging SARS-CoV-2 variants of concern. DT Skelly, AC Harding, J Gilbert-Jaramillo, ML Knight, S Longet, A Brown, ... | 52 | 2021 |
| Structure–function analysis of neutralizing antibodies to H7N9 influenza from naturally infected humans KYA Huang, P Rijal, H Jiang, B Wang, L Schimanski, T Dong, YM Liu, ... Nature microbiology 4 (2), 306-315, 2019 | 43 | 2019 |
| Broadly inhibiting antineuraminidase monoclonal antibodies induced by trivalent influenza vaccine and H7N9 infection in humans P Rijal, BB Wang, TK Tan, L Schimanski, P Janesch, T Dong, ... Journal of virology 94 (4), 10.1128/jvi. 01182-19, 2020 | 34 | 2020 |
| Characterization of influenza virus pseudotyped with ebolavirus glycoprotein JH Xiao, P Rijal, L Schimanski, AK Tharkeshwar, E Wright, W Annaert, ... Journal of Virology 92 (4), 10.1128/jvi. 00941-17, 2018 | 28 | 2018 |
| Establishment of a pig influenza challenge model for evaluation of monoclonal antibody delivery platforms A McNee, TRF Smith, B Holzer, B Clark, E Bessell, G Guibinga, H Brown, ... The Journal of Immunology 205 (3), 648-660, 2020 | 27 | 2020 |
| Inclusion of cGAMP within virus‐like particle vaccines enhances their immunogenicity L Chauveau, A Bridgeman, TK Tan, R Beveridge, JN Frost, P Rijal, ... EMBO reports 22 (8), e52447, 2021 | 26 | 2021 |
| Persistence of immune responses to the Sinopharm/BBIBP‐CorV vaccine C Jeewandara, IS Aberathna, PD Pushpakumara, A Kamaladasa, ... Immunity, inflammation and disease 10 (6), e621, 2022 | 25 | 2022 |
Alain TownsendProfessor of Molecular Immunology, Oxford UniversityDirección de correo verificada de imm.ox.ac.uk
